导致轻度认知障碍、痴呆和多种慢性病的老年人抗胆碱能负担及跌倒或跌倒相关损伤风险的药物：一项回顾性队列研究

Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.

作者信息

Green Ariel R, Reifler Liza M, Bayliss Elizabeth A, Weffald Linda A, Boyd Cynthia M

机构信息

Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Mason F. Lord Center Tower, 7th Floor, 5200 Eastern Avenue, Baltimore, MD, 21224, USA.

Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, USA.

出版信息

Drugs Aging. 2019 Mar;36(3):289-297. doi: 10.1007/s40266-018-00630-z.

DOI:10.1007/s40266-018-00630-z

PMID:30652263

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6386184/

Abstract

BACKGROUND

It is not known whether drugs with different anticholinergic ratings contribute proportionately to overall anticholinergic score.

OBJECTIVES

Our objective was to assess the risk of falls or fall-related injuries as a function of the overall anticholinergic score resulting from drugs with different anticholinergic ratings among people with impaired cognition.

METHODS

This was a retrospective cohort study of adults aged ≥ 65 years with mild cognitive impairment (MCI) or dementia and two or more additional chronic conditions (N = 10,698) in an integrated delivery system. Electronic health record data, including pharmacy fills and diagnosis claims, were used to assess anticholinergic medication use, quantified using the anticholinergic cognitive burden (ACB) scale, falls and fall-related injuries.

RESULTS

During a median follow-up of 366 days, 63% of the cohort used one or more ACB drug; 2015 (18.8%) people experienced a fall or fall-related injury. Among patients with a daily ACB score of 5, the greatest increase in risk of falls or fall-related injuries was seen when level 2 and level 3 drugs were used in combination [hazard ratio (HR) 2.06; 95% confidence interval (CI) 1.51-2.83]. Multiple ACB level 1 drugs taken together also increased the hazard of a fall or fall-related injury (HR 1.16; 95% CI 1.03-1.32). The risk of fall or fall-related injury as a function of exposure to ACB level 2 drugs (HR 1.56; 95% CI 1.16-2.10) was higher than that for ACB level 1 or 3 drugs.

CONCLUSIONS

The same daily ACB score was associated with a different degree of risk, depending on the ACB ratings of the individual drugs comprising the score. Combinations of level 2 and level 3 drugs had the greatest risk of fall or fall-related injury relative to other individuals with the same daily ACB score. Low-potency anticholinergic drugs taken together modestly increased the hazard of a fall or fall-related injury.

摘要

背景

具有不同抗胆碱能评分的药物对总体抗胆碱能评分的贡献是否成比例尚不清楚。

目的

我们的目的是评估认知功能受损人群中，因具有不同抗胆碱能评分的药物导致的总体抗胆碱能评分与跌倒或跌倒相关损伤风险之间的关系。

方法

这是一项对综合医疗服务系统中年龄≥65岁、患有轻度认知障碍（MCI）或痴呆且伴有两种或更多种其他慢性疾病的成年人进行的回顾性队列研究（N = 10698）。利用电子健康记录数据，包括药房配药和诊断索赔信息，来评估抗胆碱能药物的使用情况（使用抗胆碱能认知负担（ACB）量表进行量化）、跌倒及跌倒相关损伤情况。

结果

在中位随访期366天内，63%的队列使用了一种或多种ACB药物；2015人（18.8%）发生了跌倒或跌倒相关损伤。在每日ACB评分为5分的患者中，当2级和3级药物联合使用时，跌倒或跌倒相关损伤风险增加最为显著[风险比（HR）2.06；95%置信区间（CI）1.51 - 2.83]。同时服用多种1级ACB药物也会增加跌倒或跌倒相关损伤的风险（HR 1.16；95% CI 1.03 - 1.32）。与ACB 1级或3级药物相比，因接触2级ACB药物导致跌倒或跌倒相关损伤的风险更高（HR 1.56；95% CI 1.16 - 2.10）。

结论

相同的每日ACB评分与不同程度的风险相关，这取决于构成该评分的各个药物的ACB评级。相对于每日ACB评分相同的其他个体，2级和3级药物联合使用时发生跌倒或跌倒相关损伤的风险最大。同时服用低效抗胆碱能药物会适度增加跌倒或跌倒相关损伤的风险。

相似文献

Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.

Drugs Aging. 2019 Mar;36(3):289-297. doi: 10.1007/s40266-018-00630-z.

Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.

Drugs Aging. 2018 Mar;35(3):223-232. doi: 10.1007/s40266-018-0522-x.

Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population.

Pharmacotherapy. 2016 Nov;36(11):1123-1131. doi: 10.1002/phar.1843. Epub 2016 Nov 5.

Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.

J Clin Pharm Ther. 2018 Oct;43(5):682-694. doi: 10.1111/jcpt.12694. Epub 2018 May 4.

Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.

Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD015196. doi: 10.1002/14651858.CD015196.pub2.

Anticholinergic burden is associated with recurrent and injurious falls in older individuals.

Maturitas. 2016 Feb;84:32-7. doi: 10.1016/j.maturitas.2015.10.009. Epub 2015 Oct 23.

Effect of anticholinergic burden on treatment modification, delirium and mortality in newly diagnosed dementia patients starting a cholinesterase inhibitor: A population-based study.

Basic Clin Pharmacol Toxicol. 2019 Jun;124(6):741-748. doi: 10.1111/bcpt.13184. Epub 2019 Jan 10.

Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics.

J Alzheimers Dis. 2017;60(2):349-358. doi: 10.3233/JAD-170265.

Anticholinergic burden in adult and elderly people with intellectual disabilities: Results from an Italian multicenter cross-sectional study.

PLoS One. 2018 Oct 31;13(10):e0205897. doi: 10.1371/journal.pone.0205897. eCollection 2018.

Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.

Cochrane Database Syst Rev. 2021 May 5;5(5):CD013540. doi: 10.1002/14651858.CD013540.pub2.

引用本文的文献

Using electronic health records to understand multimorbidity in older people: a scoping review.

Eur Geriatr Med. 2025 Jul 3. doi: 10.1007/s41999-025-01231-x.

Temporal Trends of Anticholinergic Drug Exposure Among Older Adults: A 25-Year Population-Based Study.

Drug Saf. 2025 Jun 27. doi: 10.1007/s40264-025-01562-5.

Associations between patient characteristics and five-year trajectories of anticholinergic drug burden in older adults in German primary care: a prospective observational cohort study.

BMJ Open. 2025 Jun 3;15(6):e100005. doi: 10.1136/bmjopen-2025-100005.

Impact of dementia and mild cognitive impairment on bone health in older people.

Aging Clin Exp Res. 2024 Dec 27;37(1):5. doi: 10.1007/s40520-024-02871-y.

Inequalities in the Quality and Safety of Post-Diagnostic Primary Care for People With Dementia: A Scoping Review.

Int J Geriatr Psychiatry. 2024 Dec;39(12):e70035. doi: 10.1002/gps.70035.

Anticholinergic Burden and Dry Mouth Problems Among Older Adults (≥ 50 Years) Receiving Dental Care-A Retrospective, Cross-Sectional Analysis.

Clin Exp Dent Res. 2024 Dec;10(6):e70009. doi: 10.1002/cre2.70009.

Fall Risk and Medication Use Near End of Life Among Adults With Chronic Obstructive Pulmonary Disease.

Chronic Obstr Pulm Dis. 2024 Nov 22;11(6):604-610. doi: 10.15326/jcopdf.2024.0551.

Undetected falls among older adults attending medical clinics in four tertiary care centres in Sri Lanka; the need of a comprehensive geriatric assessment.

BMC Geriatr. 2024 Oct 23;24(1):864. doi: 10.1186/s12877-024-05477-1.

Evaluation of drug prescriptions on hospital admission in older trauma patients using the Fit fOR The Aged (FORTA) rules.

Z Gerontol Geriatr. 2024 Dec;57(8):609-615. doi: 10.1007/s00391-024-02359-4. Epub 2024 Sep 26.

Drugs with Anticholinergic Properties and Association with Hip Fractures in Older Patients: A Danish Nationwide Cohort-Study.

J Frailty Sarcopenia Falls. 2024 Sep 1;9(3):207-217. doi: 10.22540/JFSF-09-207. eCollection 2024 Sep.

本文引用的文献

Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.

Drugs Aging. 2018 Mar;35(3):223-232. doi: 10.1007/s40266-018-0522-x.

No Increased Risk of Fracture in Patients Receiving Antimuscarinics for Overactive Bladder Syndrome: A Retrospective Cohort Study.

J Clin Pharmacol. 2018 Jun;58(6):727-732. doi: 10.1002/jcph.1067. Epub 2018 Jan 9.

Comorbid Parkinson's disease, falls and fractures in the 2010 National Emergency Department Sample.

Parkinsonism Relat Disord. 2017 Feb;35:30-35. doi: 10.1016/j.parkreldis.2016.11.005. Epub 2016 Nov 19.

Anticholinergic Burden in Older Adults with Mild Cognitive Impairment.

J Am Geriatr Soc. 2016 Dec;64(12):e313-e314. doi: 10.1111/jgs.14554. Epub 2016 Nov 23.

Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population.

Pharmacotherapy. 2016 Nov;36(11):1123-1131. doi: 10.1002/phar.1843. Epub 2016 Nov 5.

Fall Risk Assessment Predicts Fall-Related Injury, Hip Fracture, and Head Injury in Older Adults.

J Am Geriatr Soc. 2016 Nov;64(11):2242-2250. doi: 10.1111/jgs.14439. Epub 2016 Sep 30.

Continuity of Care and Health Care Utilization in Older Adults With Dementia in Fee-for-Service Medicare.

JAMA Intern Med. 2016 Sep 1;176(9):1371-8. doi: 10.1001/jamainternmed.2016.3553.

Anticholinergic Medication Use and Risk of Fracture in Elderly Adults with Depression.

J Am Geriatr Soc. 2016 Jul;64(7):1492-7. doi: 10.1111/jgs.14182. Epub 2016 Jun 13.

Claims-based Identification Methods and the Cost of Fall-related Injuries Among US Older Adults.

Med Care. 2016 Jul;54(7):664-71. doi: 10.1097/MLR.0000000000000531.

Anticholinergic medication use and falls in postmenopausal women: findings from the women's health initiative cohort study.

BMC Geriatr. 2016 Apr 2;16:76. doi: 10.1186/s12877-016-0251-0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

导致轻度认知障碍、痴呆和多种慢性病的老年人抗胆碱能负担及跌倒或跌倒相关损伤风险的药物：一项回顾性队列研究

Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.

作者信息

Green Ariel R, Reifler Liza M, Bayliss Elizabeth A, Weffald Linda A, Boyd Cynthia M

机构信息

Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Mason F. Lord Center Tower, 7th Floor, 5200 Eastern Avenue, Baltimore, MD, 21224, USA.

Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, USA.

出版信息

Drugs Aging. 2019 Mar;36(3):289-297. doi: 10.1007/s40266-018-00630-z.

DOI:10.1007/s40266-018-00630-z

PMID:30652263

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6386184/

Abstract

BACKGROUND

It is not known whether drugs with different anticholinergic ratings contribute proportionately to overall anticholinergic score.

OBJECTIVES

METHODS

RESULTS

CONCLUSIONS

摘要

背景

具有不同抗胆碱能评分的药物对总体抗胆碱能评分的贡献是否成比例尚不清楚。

目的

我们的目的是评估认知功能受损人群中，因具有不同抗胆碱能评分的药物导致的总体抗胆碱能评分与跌倒或跌倒相关损伤风险之间的关系。

导致轻度认知障碍、痴呆和多种慢性病的老年人抗胆碱能负担及跌倒或跌倒相关损伤风险的药物：一项回顾性队列研究

Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.

作者信息

机构信息

出版信息

BACKGROUND

OBJECTIVES

METHODS

RESULTS

CONCLUSIONS

背景

目的

方法

结果

结论

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

导致轻度认知障碍、痴呆和多种慢性病的老年人抗胆碱能负担及跌倒或跌倒相关损伤风险的药物：一项回顾性队列研究

Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.

作者信息

机构信息

出版信息

BACKGROUND

OBJECTIVES

METHODS

RESULTS

CONCLUSIONS

背景

目的

方法

结果

结论